NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonates

AIMS OF THE STUDY To develop a screening tool to optimise neonatal drug prescription, which is often based on low-quality evidence. METHODS Neonatal pharmacotherapy recommendations were identified by literature review and synthesised into NeoCheck tool statements. In a two-round modified Delph...

Full description

Bibliographic Details
Main Authors: Thomas Rudolf von Rohr, Roberta de Luca, Pascal Bonnabry, Riccardo E. Pfister, Caroline Fonzo-Christe
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2021-06-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/3025
_version_ 1797974921554427904
author Thomas Rudolf von Rohr
Roberta de Luca
Pascal Bonnabry
Riccardo E. Pfister
Caroline Fonzo-Christe
author_facet Thomas Rudolf von Rohr
Roberta de Luca
Pascal Bonnabry
Riccardo E. Pfister
Caroline Fonzo-Christe
author_sort Thomas Rudolf von Rohr
collection DOAJ
description AIMS OF THE STUDY To develop a screening tool to optimise neonatal drug prescription, which is often based on low-quality evidence. METHODS Neonatal pharmacotherapy recommendations were identified by literature review and synthesised into NeoCheck tool statements. In a two-round modified Delphi process, experts from Swiss neonatal intensive care units (NICUs) rated their agreement with individual statements using a five-point Likert scale (5 = totally agree). Statements with >65% scores ≥4 in round 1 and >75% scores ≥4 in round 2 were selected. RESULTS We identified 1375 clinical guidelines via literature review. After synthesis, 158 statements were submitted to 23 experts (1 clinical pharmacist, 22 neonatologists; 65% with >10 years neonatology practice) from 10 Swiss NICUs. Nineteen items did not reach the agreement threshold and were eliminated in the second Delphi round. The final NeoCheck tool comprises 141 statements in 11 medical domains concerning 49 neonatal diseases. Most (79%) statements concern all neonates, 13% concern preterm (<37 weeks gestational age) infants and 3% concern very preterm (<32 weeks gestational age) infants CONCLUSIONS NeoCheck is the first prescription-screening tool developed to optimise neonatal pharmacotherapy. In a future prospective study, its effect on NICU prescription optimisation and the quality of care will be assessed.
first_indexed 2024-04-11T04:27:23Z
format Article
id doaj.art-adcd54e159634bd68bbfa5aa11a9fac7
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2024-04-11T04:27:23Z
publishDate 2021-06-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-adcd54e159634bd68bbfa5aa11a9fac72022-12-29T16:01:34ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972021-06-01151252610.4414/smw.2021.20519NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonatesThomas Rudolf von Rohr0Roberta de Luca1Pascal Bonnabry2Riccardo E. Pfister3Caroline Fonzo-Christe4Pharmacy, Geneva University Hospitals, Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, SwitzerlandNeonatology Unit, Hôpital de la Tour, Meyrin, SwitzerlandPharmacy, Geneva University Hospitals, Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, SwitzerlandNeonatology and Paediatric Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandPharmacy, Geneva University Hospitals, Geneva, Switzerland; Neonatology and Paediatric Intensive Care Unit, Geneva University Hospitals, Geneva, Switzerland AIMS OF THE STUDY To develop a screening tool to optimise neonatal drug prescription, which is often based on low-quality evidence. METHODS Neonatal pharmacotherapy recommendations were identified by literature review and synthesised into NeoCheck tool statements. In a two-round modified Delphi process, experts from Swiss neonatal intensive care units (NICUs) rated their agreement with individual statements using a five-point Likert scale (5 = totally agree). Statements with >65% scores ≥4 in round 1 and >75% scores ≥4 in round 2 were selected. RESULTS We identified 1375 clinical guidelines via literature review. After synthesis, 158 statements were submitted to 23 experts (1 clinical pharmacist, 22 neonatologists; 65% with >10 years neonatology practice) from 10 Swiss NICUs. Nineteen items did not reach the agreement threshold and were eliminated in the second Delphi round. The final NeoCheck tool comprises 141 statements in 11 medical domains concerning 49 neonatal diseases. Most (79%) statements concern all neonates, 13% concern preterm (<37 weeks gestational age) infants and 3% concern very preterm (<32 weeks gestational age) infants CONCLUSIONS NeoCheck is the first prescription-screening tool developed to optimise neonatal pharmacotherapy. In a future prospective study, its effect on NICU prescription optimisation and the quality of care will be assessed. https://www.smw.ch/index.php/smw/article/view/3025neonatepharmacotherapypotentially inappropriate medicationprescription-screening toolQuality of Care
spellingShingle Thomas Rudolf von Rohr
Roberta de Luca
Pascal Bonnabry
Riccardo E. Pfister
Caroline Fonzo-Christe
NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonates
Swiss Medical Weekly
neonate
pharmacotherapy
potentially inappropriate medication
prescription-screening tool
Quality of Care
title NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonates
title_full NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonates
title_fullStr NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonates
title_full_unstemmed NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonates
title_short NeoCheck: a prescription-screening tool to optimise pharmacotherapy for hospitalised neonates
title_sort neocheck a prescription screening tool to optimise pharmacotherapy for hospitalised neonates
topic neonate
pharmacotherapy
potentially inappropriate medication
prescription-screening tool
Quality of Care
url https://www.smw.ch/index.php/smw/article/view/3025
work_keys_str_mv AT thomasrudolfvonrohr neocheckaprescriptionscreeningtooltooptimisepharmacotherapyforhospitalisedneonates
AT robertadeluca neocheckaprescriptionscreeningtooltooptimisepharmacotherapyforhospitalisedneonates
AT pascalbonnabry neocheckaprescriptionscreeningtooltooptimisepharmacotherapyforhospitalisedneonates
AT riccardoepfister neocheckaprescriptionscreeningtooltooptimisepharmacotherapyforhospitalisedneonates
AT carolinefonzochriste neocheckaprescriptionscreeningtooltooptimisepharmacotherapyforhospitalisedneonates